Linde’s health care division provides medical gas and pharmaceutical offerings for the treatment of a variety of clinical conditions such as aerosol therapy, oxygen therapy, asthma, anesthesia, chronic obstructive pulmonary disease, sleep apnea and pain. Also, Linde’s subsidiary LifeGas has been doing business with Lincare for several years now. was through its Homecare business, which supplied products to other home health care companies in the U.S. Prior to the Lincare acquisition, Linde’s connection with the U.S.
The merger will enable Linde to become the global leader in health care offerings within the gases industry. Two-thirds of the €12 billion global health care industry is dedicated to homecare products with an annual growth rate of roughly 6%. The company offers services and equipment to more than 800,000 clients across the U.S. health care market, which is the largest in the world.įlorida-based Lincare is a leading provider of oxygen and other respiratory therapy services to patients at home. With this acquisition, Linde will be able to double its sales in the North American Gases business and target the €4 billion U.S. home health care market are Gentiva Health Services Inc. BD adds infectious disease expert Dr.The merger should be accretive for Linde as it will be able to expand its market base significantly, especially in the U.S.HHS, DOD invest more than $562M to increase COVID-19 test manufacturing.
Lincare a linde company trial#
LifeScan launches digital diabetes management platform.PerkinElmer launches cloud-based research suite for pharmaceutical customers.GE rises on Street-beating Q3, raised guidance.Material from Reuters was used in this reportįiled Under: Legal News Tagged With: Lincare, Linde Under the settlement deal, the US government will receive $9 million, with $11 million going to the former employees. The case originally began as 2 separate suits filed in 20 by ex-employees in New York state and Massachusetts. “The matter was resolved to the satisfaction of all involved, with no admission of liability by any party,” Lincare said in a statement. Lincare said that it had followed set regulations and the lawsuit was challenging “garden variety” billing errors. The suit alleged the company also paid kickbacks to physicians and their families for patient referrals, supplying them with oxygen and supplies for free. The ex-employees also alleged that the company fabricated customer oxygen orders and improperly waived customer co-payments and deductibles. In the case, former employees claimed that the company has billed government health programs, including Medicare, since 2003 for oxygen equipment and tanks even when the customers did not use or require them. The case, filed under the False Claims Act by former employees, was dismissed with prejudice by US District Judge Douglas Woodcock yesterday, according to court documents. Linde AG’s business unit Lincare is paying $20 million to resolve a whistleblower suit alleging that the company fraudulently billed the US government for oxygen and respiratory care equipment.
0 kommentar(er)
